Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Relief For UniQure Hemophilia Program Sends Ball To FTC’s Court
Good News For Gene Therapy Continues As FDA Also Removes Hold On Voyager’s Huntington’s Trial
Apr 26 2021
•
By
Alaric DeArment
FDA lifts hold on uniQure's hemophilia B program • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Clinical Trials
More from R&D